Marmer Medical Eye Center Atlanta, GA - 30315

Marmer Medical Eye Center is categorized under Ophthalmologists in Atlanta, GA and active since 1975.

Marmer Medical Eye Center was established in 1975, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Ophthalmologists business, which does work in the B2C market, and is classified as a Ophthalmologists, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Robert Marmer, Owner at the company’s single location by writing to 777 Cleveland Avenue Sw # 102, Atlanta, Georgia GA 30315 or by phoning (404) 768-0194. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Marmer Medical Eye Center
Contact Person: Robert Marmer, Owner
Address: 777 Cleveland Avenue Sw # 102, Atlanta, Georgia 30315
Phone Number: (404) 768-0194
Website Address: marmer2020.com
Annual Revenue (USD): $500.000 to $999.999
Founded: 1975
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Ophthalmologists
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Marmer Medical Eye Center was started in 1975 to provide professional Ophthalmologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Robert Marmer, Owner for inquiries that concern Marmer Medical Eye Center by calling the company number (404) 768-0194, as your correspondence is most welcome. Additionally, the physical location of the single location of Marmer Medical Eye Center can be found at the coordinates 33.68133,-84.41479 as well as the street address 777 Cleveland Avenue Sw # 102 in Atlanta, Georgia 30315.

For its online presence, you may visit Marmer Medical Eye Center’s website at marmer2020.com and engage with its social media outlets through on Twitter and on Facebook.